89BIO

89bio-logo

89bio is a clinical-stage biopharmaceutical company focused on rapidly advancing our lead product candidate, BIO89-100, through clinical development for the treatment of non-alcoholic steatohepatitis (NASH). BIO89-100 is a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21). It may be a differentiated FGF21 therapy, and we believe it has the potential to become a mainstay of therapy for NASH given its ability to address the key liver pathologies (steatosis and fibrosis) and underlying metabolic dysregulation in patients with NASH. We are also expanding the breadth of indications for BIO89-100 with an initial focus on severe hypertriglyceridemia (SHTG).

#SimilarOrganizations #People #Financial #Website #More

89BIO

Industry:
Biopharma Biotechnology Pharmaceutical

Founded:
2018-01-01

Address:
San Francisco, California, United States

Country:
United States

Website Url:
http://www.89bio.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
238.3 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics


Similar Organizations

aerial-biopharma-logo

Aerial BioPharma

Aerial BioPharma is a biopharmaceutical company developing biologics and small molecules for central nervous system issues.

blossomhill-therapeutics-logo

BlossomHill Therapeutics

BlossomHill Therapeutics, Inc. is a biopharmaceutical company focusing on oncology and autoimmune disorders.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

harmony-biosciences-logo

Harmony Biosciences

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

innovent-biologics-logo

Innovent Biologics

Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.

ksq-therapeutics-logo

KSQ Therapeutics

KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.

phasebio-pharmaceuticals-logo

PhaseBio Pharmaceuticals

PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

sirnaomics-logo

Sirnaomics

Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.


Current Advisors List

michael-hayden_image

Michael Hayden Board Member @ 89bio
Board_member

anat-naschitz_image

Anat Naschitz Board Member @ 89bio
Board_member
2018-05-01

Current Employees Featured

ryan-martins_image

Ryan Martins
Ryan Martins Chief Financial Officer @ 89bio
Chief Financial Officer
2019-04-01

hank-mansbach_image

Hank Mansbach
Hank Mansbach Chief Medical Officer @ 89bio
Chief Medical Officer
2018-12-01

quoc-le-nguyen_image

Quoc Le-Nguyen
Quoc Le-Nguyen Chief Technical Operations Officer and Head of Quality @ 89bio
Chief Technical Operations Officer and Head of Quality
2019-01-01

ram-waisbourd_image

Ram Waisbourd
Ram Waisbourd Chief Operating Officer and Chief Business Officer @ 89bio
Chief Operating Officer and Chief Business Officer
2018-05-01

rohan-palekar_image

Rohan Palekar
Rohan Palekar CEO @ 89bio
CEO
2018-07-01

Founder


michael-hayden_image

Michael Hayden

Stock Details


Company's stock symbol is NASDAQ:ETNB

Investors List

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series A - 89bio

longitude-capital_image

Longitude Capital

Longitude Capital investment in Series A - 89bio

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series A - 89bio

pontifax_image

Pontifax

Pontifax investment in Series A - 89bio

Official Site Inspections

http://www.89bio.com Semrush global rank: 3.7 M Semrush visits lastest month: 3.75 K

  • Host name: 184.106.55.132
  • IP address: 184.106.55.132
  • Location: Lansing United States
  • Latitude: 42.7348
  • Longitude: -84.6245
  • Metro Code: 551
  • Timezone: America/Detroit
  • Postal: 48917

Loading ...

More informations about "89bio" on Search Engine